Covid-19 streamlined FDA rules, and pharma's pushing to keep it that way

Covid-19 streamlined FDA rules, and pharma's pushing to keep it that way

STAT Plus: The FDA got a lot more flexible during Covid — and pharma’s already pushing to make it permanent

By NICHOLAS FLORKO

ANDREW HARNIK/AP

The drug industry made it clear to the FDA that it wants the regulatory flexibilities the agency embraced during the Covid-19 pandemic to be made permanent.

READ MORE